Sitemap  

  
Home Page About ISMP ISMP Medication Safety Newsletters Teleconferences ISMP Message Board Report Medication Errors to ISMP ISMP Online Store Consulting Services Support ISMP FAQ Contact Us

Hazard Alert!

Click here for printer friendly version

From the June 5, 2008 issue

Acetaminophen concentrated drops in 1-pint pour bottle. Brookstone Pharmaceuticals has begun marketing a pint-size container (473 mL) of acetaminophen concentrated drops (80 mg/0.8 mL) called PEDIAPHEN (see photo in the PDF version of the newsletter). In advertisements, the company suggests that hospitals can help protect the environment by purchasing their new large-volume, “green” container of acetaminophen. Print advertisements also compare Pediaphen to Tylenol brand acetaminophen concentrated drops (in 15 mL bottles), noting that Pediaphen’s larger container saves time dispensing the drug and costs less than thirty-two small-volume Tylenol containers. But saving time, money, and the environment may come with a hefty price tag in terms of serious medication errors. Such a large container invites confusion between the concentrated drops (80 mg/0.8 mL, or 100 mg/mL) and children’s acetaminophen liquid or elixir (160 mg/5 mL, or 32 mg/mL). Smaller containers of the concentrated drops from Tylenol and other companies are dispensed in a dropper bottle to promote correct dosing using dropperfuls. The screw cap on the Pediaphen container suggests that the dose should be poured into a medicine cup, similar to children’s acetaminophen liquid or elixir. Safety takes a giant step backwards if organizations purchase and dispense products in large bulk containers. Limited quantities and affordances (e.g., small dropper bottle, cusps around the bottle opening to prevent pouring the medication into a cup) are important safety features because they cue practitioners that small-volume dosing is required. We fully support healthcare’s efforts to “go green,” but not at the cost of public safety. Another issue is that “Pediaphen” may lead to name confusion with other children’s products that begin with “Pedia...” In 1989, when McNeil launched PEDIAPROFEN, an ibuprofen suspension, mix-ups began to occur with PEDIAPRED, a liquid prednisolone product. For that reason, Pediaprofen was renamed CHILDREN’S MOTRIN. We have alerted the manufacturer and FDA about our concerns with the pint-size Pediaphen product. 

Resources
Acute Care Main Page
Current Issue
Past Issues
Recent articles
Survey Results
Action Agendas - Free CE's
Hazard Alerts
Subscribe
Contest Winners
Newsletter Editions
Acute Care
Community/Ambulatory
Nursing
Consumer
 
Dontate to ISMP

Home | Contact UsEmployment  | Legal Notices | Donate to ISMP | Med-E.R.R.S.
  ISMP Canada |  ISMP Spain | Pennsylvania Patient Safety Authority

200 Lakeside Drive, Suite 200, Horsham, PA 19044
Phone: (215) 947-7797,  Fax: (215) 914-1492

© 2008 Institute for Safe Medication Practices. All rights reserved

HON @ Code
Health On the Net Foundation
Health Impact Award
Health Impact Award